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BACKGROUND. Few intervention studies have been conducted to help couples
manage the effects of prostate cancer and maintain their quality of life. The
objective of this study was to determine whether a family-based intervention
could improve appraisal variables (appraisal of illness or caregiving, uncertainty,
hopelessness), coping resources (coping strategies, self-efficacy, communication),
symptom distress, and quality of life in men with prostate cancer and their
spouses.
METHODS. For this clinical trial, 263 patient-spouse dyads were stratified by
research site, phase of illness, and treatment; then, they were randomized to the
control group (standard care) or the experimental group (standard care plus a 5-
session family intervention). The intervention targeted couples’ communication,
hope, coping, uncertainty, and symptom management. The final sample con-
sisted of 235 couples: 123 couples in the control group and 112 couples in the ex-
perimental group. Data collection occurred at baseline before randomization and
at 4 months, 8 months, and 12 months.
RESULTS. At 4-month follow-up, intervention patients reported less uncertainty
and better communication with spouses than control patients, but they reported
no other effects. Intervention spouses reported higher quality of life, more self-
efficacy, better communication, and less negative appraisal of caregiving, uncer-
tainty, hopelessness, and symptom distress at 4 months compared with controls,
and some effects were sustained to 8 months and 12 months.
CONCLUSIONS. Men with prostate cancer and their spouses reported positive out-
comes from a family intervention that offered them information and support.
Programs of care need to be extended to spouses who likely will experience mul-
tiple benefits from intervention. Cancer 2007;110:2809–18.  2007 American
Cancer Society.
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P rostate cancer is the most common cancer among men and isaccompanied by serious treatment-related side effects, such as
urinary incontinence and erectile dysfunction. These symptoms per-
sist over time and can have a negative effect on the quality of life
(QOL) of both men and their spouses.1 Patients with prostate cancer
often rely exclusively on their spouses for support and seldom dis-
cuss their concerns with others, possibly because of the intimate na-
ture of the problems.2 Consequently, the role of primary caregiver
can be stressful for spouses. Several investigators have observed that
spouses of men with prostate cancer report significantly more emo-
tional distress than their husbands.1,3 Spouses’ higher distress may
be related to their limited support from others, communication pro-
blems with partners, high uncertainty, and lower caregiver self-
efficacy to manage the effects of the illness.4
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Despite the serious problems that prostate can-
cer creates for patients and their spouses, there are
surprisingly few intervention programs to help cou-
ples manage the effects of illness and maintain their
QOL.3,5 Prior randomized clinical trials (RCTs) have
reported primarily on patient outcomes,6–10 and only
a few studies have reported spouse outcomes.3,5,11 In
addition, most behavioral interventions have been
conducted during the newly diagnosed phase of
prostate cancer,6–10 but there are no intervention stu-
dies in the biochemical recurrence and advanced
phases. Some men with prostate cancer are at greater
risk of developing more distress than others, yet few
studies have assessed patients’ risk for distress to
determine who is in need of psychosocial interven-
tions.
Investigators have tested a variety of intervention
formats (eg, computer-based, telephone, group) with
some positive effects on patient outcomes, such as
improved sexual function7,10 or urinary control,9 bet-
ter cognitive reframing and problem solving,9 more
active decision-making,6 and better mental health
(eg, less anxiety, depression, or worry).6–8,10 However,
most intervention effects have been obtained at
short-term follow-up, with only a few effects sus-
tained over time.
To our knowledge, only 3 RCTs published to date
have reported spouse outcomes.3,5,11 A single, presur-
gical intervention session was offered to couples to
enhance communication within the couple and with
the medical team,5 a comprehensive homecare inter-
vention was offered to couples,11 and a group psy-
choeducational intervention was offered to spouses
only.3 Spouses in the intervention arms of these stu-
dies reported less general stress,5 more appreciation
for life, personal strength, spiritual growth, less
denial,3 and more caregiver preparedness (on quali-
tative reports)11 after the intervention than spouses
in the control groups.
Although prior RCTs with prostate cancer
patients and their spouses have laid important
groundwork, more trials are needed to examine
patient and spouse outcomes across the phases of
illness. The objective of this study was to determine
whether a family-based intervention could improve
appraisal variables (appraisal of illness or caregiving,
uncertainty, hopelessness), coping resources (coping
strategies, self-efficacy, communication), symptom
distress (general and prostate-specific), and QOL in
patients and their spouses during 3 phases of pros-
tate cancer (newly diagnosed, biochemical recur-
rence, and advanced). A stress-coping framework,
which was adapted from the work of Lazarus and
Folkman,12 guided this study and the selection of
variables. We hypothesized that couples who
received the family intervention (FOCUS Program)
would report fewer negative outcomes on appraisal
variables, more positive outcomes on coping
resources, and higher QOL than couples in the con-
trol group. We also examined 2 potential modera-
tors—phase of prostate cancer and risk for distress—
to determine whether either moderator created a dif-




An RCT with follow-up assessments at 4 months, 8
months, and 12 months was used to examine the
effects of a family-based intervention on study out-
comes of patients and their spouses/partners.
Detailed information regarding sample accrual and
retention13 and on the baseline characteristics of par-
ticipants4 have been described previously. For this
report, we examined the effects of the intervention
on patient and spouse outcomes at initial follow-up
(4 months) and at long-term follow-up (8 months
and 12 months).
Sample
Patients were eligible if they were in 1 of 3 phases of
prostate cancer (ie, newly diagnosed, biochemical re-
currence, or advanced). We sought a cohort of
patients and spouses in each phase who were facing
either a new diagnosis, new biochemical recurrence,
or new metastases or progression of advanced dis-
ease, ie, dyads that were considered more likely to
benefit from the intervention. For each phase, there
was a 2-month period of eligibility: 1) newly diag-
nosed, after the completion of primary treatment; 2)
biochemical recurrence after 2 consecutive rises in
their PSA; and 3) advanced, after diagnosis or pro-
gression of metastatic disease. Other patient criteria
included age 30 years, a life expectancy 12
months, a spouse or live-in partner; and residence
within 75 miles of participating cancer centers.
Patients with second primary cancers were excluded.
Spouses/partners were eligible if they were aged
21 years and were identified by patients as their
primary caregiver (ie, provider of emotional and/or
physical care). Couples were excluded if spouses had
been diagnosed with cancer within the prior year or
were receiving cancer treatment.
Procedures
Eligible participants were identified by staff in sur-
gery, radiation, and medical oncology clinics at 3
2810 CANCER December 15, 2007 / Volume 110 / Number 12
research sites. Potential participants were contacted
by research staff and, if they agreed to be enrolled,
were scheduled for a home visit to complete consent
forms approved by institutional review boards and to
collect baseline data. Patients were stratified by treat-
ment centers (3 sites), phase of illness (3 phases),
and type of treatment; then, they were randomized
with spouses into control or experimental treatment
arms. Data collection nurses who were blinded to
group assignment collected data from couples at
baseline and at 4 months, 8 months, and 12 months.
A separate team of masters-prepared nurses deliv-
ered the intervention. Only assessments that were




Couples in the control group received standard clinic
care at their cancer center that addressed primarily
diagnosis and treatment of patients’ disease.
Although the centers offered some support groups,
no specific psychosocial resources were targeted for
couples facing prostate cancer.
Experimental condition
Couples in the experimental group received standard
clinic care plus a family-based intervention called
the FOCUS Program, a supportive-educative inter-
vention that was tested initially with breast cancer
patients and their family caregivers14,15 and was
modified to address the needs of prostate cancer
patients and their spouses. The program consists of
3 90-minute home visits and 2 30-minute telephone
sessions spaced 2 weeks apart and delivered between
baseline and 4 months.
The content consists of 5 core areas represented
by the acronym FOCUS: Family involvement, Opti-
mistic attitude, Coping effectiveness, Uncertainty
reduction, and Symptom management. Interven-
tions that pertained to family involvement encour-
aged couples to work as a team, communicate
openly about the illness, and provide one another
with support. Optimistic attitude interventions
helped couples maintain hope and focus on achiev-
able, short-term goals. Coping effectiveness interven-
tions emphasized techniques to reduce stress, active
coping strategies, and healthy lifestyle behaviors.
Uncertainty reduction interventions taught couples
how to obtain information and ways to live with
uncertainty. Symptom management interventions
included self-care strategies to manage symptoms
both experienced. Although the program had core
areas, the content also was targeted to the needs of
couples across the 3 phases of prostate cancer and
tailored to the needs of individual couples within
phases.
Intervention nurses were trained by the princi-
pal investigator (PI) and coinvestigators during a
40-hour training program, viewed a FOCUS inter-
vention training video, and accompanied experi-
enced intervention nurses on multiple in-home
intervention sessions before they started their own
caseloads. Several strategies were implemented to
maintain treatment fidelity. Intervention nurses 1)
completed a 21-page protocol checklist that out-
lined interventions for each session; 2) recorded the
percent of time they spent on the FOCUS compo-
nents in each session; 3) audiotaped randomly
selected home visits, which were reviewed by the PI
for consistency with protocol guidelines; and 4) pro-
vided case presentations to the PI and other inter-
vention nurses at monthly, 2-hour staff meetings to
ensure they were intervening consistently within
and across cases.
An analysis of 30 randomly selected protocol
checklists indicated that 98.3% of the interventions
were documented as adhering to the manualized
protocol. Review of audiotaped sessions indicated
that the intervention was delivered with competence
(eg, provided accurate information that was respon-
sive to participants’ concerns) and was consistent
with protocol guidelines. Furthermore, the percent of
time spent on FOCUS components was similar
among all intervention nurses. These indicators sug-
gested that treatment fidelity consistently was high.
Instruments
Established instruments were used to measure all
study variables. Internal consistency reliabilities for
each measure were assessed across all 4 administra-
tions. The mean a reliability coefficients are listed in
Tables 1 and 2.
Quality of life
A general QOL measure, the Medical Outcomes
Study 12-item short form (MOS SF-12) (version 2),16
and a cancer-specific measure, the general Func-
tional Assessment of Cancer Treatment (FACT-G)
(version 4),17 were used to assess patients’ and
spouses’ QOL. The MOS SF-12 yields summary
scores for physical and mental QOL. The 27-item
FACT-G assessed overall QOL. Because each indivi-
dual reported on his or her own QOL, spouses’
FACT-G required slight wording modifications.
Patients also completed a prostate-specific QOL
scale, the FACT-P.
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Appraisal variables
Appraisals of illness/caregiving were assessed with
separate, 27-item Appraisal of Illness or Appraisal of
Caregiving Scales.18 These scales measure patients’
level of threat associated with the illness and
spouses’ perception of caregiving. Uncertainty was
assessed with the 28-item Mishel Uncertainty in Ill-
ness Scale,19 and hopelessness was assessed with the
20-item Beck Hopelessness Scale.20
Coping resource variables
Coping strategies were assessed with the 28-item
Brief Coping Orientations to Problems Experienced
scale,21 that was factor analyzed into active and avoi-
dant coping dimensions. Self-efficacy was assessed
with the 17-item Lewis Cancer Self-efficacy Scale,
which measures confidence in managing stress and
changes associated with cancer or treatments.22
Communication about the illness was assessed with
the 32-item Lewis Mutuality and Interpersonal Sensi-
tivity Scale.22
Symptoms
General symptom distress was measured with the 16-
item Symptom Scale of the Omega Screening Ques-
tionnaire (OSQ).23 Both patients and spouses rated
how much they were experiencing symptoms such as
fatigue and sleeping problems. Prostate-specific
symptoms were assessed with the 50-item Expanded
Prostate Cancer Index Composite (EPIC), which
measures patients’ urinary, bowel, sexual, and hor-
mone symptoms.24 Spouses completed the 4-item
spousal version of the EPIC, which assessed the
extent to which husbands’ prostate-specific symp-
toms created problems for spouses. Concurrent va-
lidity of the spouse EPIC was established by the
significant correlations between patients’ and
spouses’ scores on the scales (all P < .001).4
Risk for distress
The risk of developing future emotional distress was
measured (at baseline only) with the 77-item OSQ,
developed by Mood and Bickes23 from the original
Omega Clinical Screening Interview.25,26 The OSQ
assesses demographics, health history, current con-
cerns, and symptom distress and yields a composite
risk score that ranges from 0 to 23 (high risk, 9)
with good reliability and validity.
Data Analysis
Chi-square analyses and Student t tests were con-
ducted to assess any differences between the inter-
vention and control groups at baseline. To assess the
effectiveness of the intervention, random-effects
regression analyses were conducted. Random-effects
regression models use an iterative method that esti-
mates a trajectory for each participant based on all
available data for that participant augmented by data
from the whole sample. These analyses have advan-
tages over traditional analysis of variance models:
They allow the use of all available data from all parti-
cipants rather than dropping participants with miss-
ing data, and they incorporate serial correlations
among observations over time, which results in less
bias. To control for multiple tests, the a was reduced
to P  .01 (test of significance). Values obtained
between P > .01 and P  .05 were considered statisti-
cal trends. In addition, effect sizes were calculated for
all comparisons (Tables 1, 2). Three a priori, planned
comparisons were conducted comparing the inter-
vention and control groups at 4-, 8-, and 12-month
assessments and controlling for baseline scores.
RESULTS
Description of the Sample
During a 3-year period of recruitment, 429 patients
were referred to the study from clinic staff. Of these
referrals, 46 patient-spouse dyads did not meet all
eligibility criteria, and 120 dyads refused study parti-
cipation. Reasons for refusal varied but generally
were because patients were too ill or because of
competing priorities within the dyad. The remaining
263 dyads (68.7%) enrolled and completed baseline
assessments.
Of the 263 enrolled dyads, 235 dyads (90%) com-
pleted the 4-month assessment, and 218 dyads (83%)
completed all 3 follow-up assessments. The final
sample for all analyses consisted of 235 dyads with
at least 1 follow-up assessment (112 intervention
dyads and 123 control dyads) (see Fig. 1). Comparing
the intervention and control groups, there were no
significant differences in the number of follow-up
assessments, the number of participants lost to fol-
low-up, the number of participants who completed
all follow-up assessments, or participants lost to
other reasons (all P > .10). Among the 45 dyads that
did not complete the study, reasons included patient
death (15 dyads; 33.3%), declined intervention (9
dyads; 20%), too busy (6 dyads; 13.3%), and other
reasons (15 dyads; 33.3%) (for details, see Northouse
et al.13).
The average age of patients in the final sample
(N 5 235) was 63 years (standard deviation, 9.1
years; range, 42-90 years), and the average age of
spouses was 59 years (standard deviation, 9.7 years;
range, 34-84 years). Eighty-four percent of dyads
were Caucasian, 14% were African American, and 2%
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were Hispanic, Asian, Native American, or mixed
race. Patients and spouses reported averages of 16
years and 15 years of formal education, respectively.
The median family income ranged from $50,000 to
$75,000.
Sixty-five percent of patients were in the newly
diagnosed phase. Of those, 60% underwent prosta-
tectomy, and 40% received external beam radiation.
Fourteen percent of patients were in the biochem-
ical recurrence phase, with 50% under observation
and 50% under treatment (primarily hormones).
Twenty-one percent of patients were in the
advanced phase, with 36% receiving hormone treat-
ments and 64% receiving hormone-refractory treat-
ments (eg, chemotherapy). Thirty-seven percent of
patients had a family history of cancer, and 68%
had other health problems, such as arthritis or heart
disease. Approximately 25% of the spouses had
health problems, such as arthritis or back pain.
There were no significant differences between
patients and spouses in the intervention and control
groups on primary study variables or demographics
at baseline, which demonstrated the effectiveness of
randomization.
Major Study Outcomes
Table 1 provides adjusted means for patients in the
intervention and control groups at the 4-, 8-, and 12-
month assessments, controlling for their own base-
line scores, using estimated values for missing data,
and maintaining the sample size across all assess-
ment periods. Table 2 provides comparable data for
spouses.
Patient outcomes
There were no differences between intervention and
control patients on any QOL variables. On the ap-
praisal variables, the 2 groups did not differ on ap-
praisal of illness, but they did differ on uncertainty.
FIGURE 1. Flow of couples through
clinical trial.
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Patients in the intervention group reported less
uncertainty about their illness than controls at 4
months (mean score, 56.9 vs 60; P < .05).
Patient groups differed on 1 coping resource
variable. Intervention patients reported more com-
munication about the illness with their spouses than
control patients at 4 months (mean score, 3.80 vs
3.69; P < .05). There were no differences between
groups on general symptom distress or on prostate-
specific symptoms. No significant effects of the inter-
vention were observed for patients at 8 months or 12
months.
Spouse outcomes
Several intervention effects were observed for
spouses (see Table 2). On the MOS SF-12, interven-
tion spouses reported better physical QOL than con-
trols at 8 months (mean score, 44.9 vs 42.9; P < .05)
and at 12 months (mean score, 44.6 vs 42.3; P < .01),
although there were no differences between groups
at 4 months. In addition, intervention spouses had
better SF-12 mental QOL scores (mean score, 50.9 vs
49; P < .05) and overall FACT-G QOL scores (mean
score, 86.5 vs 83.5; P < .01) than controls at 4
months, but not at 8 months or 12 months.
There were several differences on the appraisal
variables for spouses. Intervention spouses had sig-
nificantly less negative appraisal of caregiving (mean
score, 2.29 vs 2.44; P < .01), significantly less uncer-
tainty about the illness (mean score, 59.5 vs 63.1;
P < .01), and less hopelessness (mean score, 2.47 vs
3.07; P < .05) than control spouses at 4 months.
Uncertainty continued to be lower for intervention
spouses versus control spouses at 8 months (mean
score, 59.5 vs 62.2; P 5 .05).
Among the coping resource variables, interven-
tion spouses had higher self-efficacy about ways to
manage the illness than control spouses at 4 months
(mean score, 144.1 vs 138.8; P < .05) and 12 months
(mean score, 143.8 vs 137.8; P < .05). In addition,
intervention spouses had better communication with
patients than control spouses across all 3 assess-
ments: at 4 months (mean score, 3.74 vs 3.57; P <
.01), 8 months (mean score, 3.66 vs 3.52; P < .05),
and 12 months (mean score, 3.66 vs 3.50; P < .01).
Although there were no differences in active coping
at 4 months and 8 months, intervention spouses
used more active coping at 12 months than control
spouses (mean score, 30.5 vs 28.9; P < .05).
Finally, intervention spouses had significantly
less general symptom distress of their own than con-
trol spouses (mean score, 5.10 vs 6.28; P < .01) and
had fewer problems related to their husbands’ uri-
nary incontinence at 4 months (mean score, 1.60 vs
1.85; P < .05) and at 8 months (mean score, 1.53 vs
1.81; P < .01).
Moderator effects
We tested for 2 moderator effects: phase of illness
(newly diagnosed, biochemical recurrence, advanced
disease) and risk for distress. No moderation was
observed, suggesting that the effectiveness of the
intervention was not moderated by either variable.
DISCUSSION
One important finding of this study was the benefit
spouses of men with prostate cancer received from a
family-based intervention that was offered jointly to
patients and spouses. The intervention had many
positive effects, extending across a number of vari-
ables that improved spouses’ appraisal of the care-
giving experience, increased their ability to cope, and
enhanced their physical and mental QOL. Although
patients also obtained benefits from the intervention,
the effects were far greater for their spouses.
Why did spouses benefit so much from the
intervention? Spouses had a greater need for the
intervention than patients. Prior research indicates
that spouses have more distress than patients1,3 yet
receive less support.4 The intervention provided
spouses with information and support that reduced
their negative appraisal of caregiving, decreased
their uncertainty, and lessened their hopelessness.
Spouses also learned ways to cope with the stress of
caregiving and to manage the symptoms experi-
enced by patients. These strategies may have
accounted for spouses’ higher caregiver efficacy,
fewer problems with patients’ symptoms (urinary),
and better overall QOL than control spouses. McMil-
lan et al.27 observed that caregivers who learned
coping skills had better QOL than caregivers who
received support only. Spouses’ coping resources (ie,
self-efficacy, communication, active coping strate-
gies) were better for the intervention group than for
the control group at the 12-months follow-up, sug-
gesting that intervention effects on these variables
endured over time.
Spouses who received the intervention reported
less symptom distress of their own at 4 months and
better physical QOL than control spouses at 8
months and 12 months. These are particularly im-
portant findings, because caregiving stress has been
associated with poorer physical health and higher
mortality among caregivers.28 Intervention spouses,
who were encouraged to seek care for their own
health problems and to engage in healthy lifestyle
behaviors (exercise, nutrition), appeared to show
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improved health. The improvements in physical QOL
did not appear until 8 months and 12 months post-
intervention, suggesting that positive changes in
physical health may take time to develop.
Couples who participated in the intervention were
able to communicate more effectively about the ill-
ness than control couples. This is noteworthy in view
of multiple studies that have identified communica-
tion problems in couples with prostate cancer.2 The
intervention was offered jointly to patients and
spouses, allowing both individuals to obtain first-hand
information, to have their questions answered, and to
hear the concerns of their partner. Manne et al.3
offered an intervention to spouses only and observed
no effects on marital communication, concluding that
interventions designed to affect the marital system (ie,
communication) need to include both partners.
Patients who participated in the intervention had
2 positive outcomes at initial follow-up (less uncer-
tainty, better communication), but they had no sus-
tained effects and no effects on symptoms or on
their QOL. More targeted or higher dose interven-
tions may be needed to address prostate-specific
symptoms. For example, Mishel et al.9 assisted
patients with prostate cancer in managing urinary
incontinence by teaching them Kegel exercises and
offering weekly telephone reinforcement for 8 weeks.
With regard to QOL scores, because the majority of
patients were in the newly diagnosed phase, with
high FACT-G QOL scores similar to those in the nor-
mal population,29 there was little room for improve-
ment. Giesler et al.7 also observed no intervention
effects on QOL outcomes in patients with newly
diagnosed prostate cancer. Furthermore, all patients
(intervention and control) had spouses as their pri-
mary caregivers, who may have buffered the stress of
illness and lessened intervention effects on patients.
We also observed no differential effect of the
intervention according to patients’ phase of illness or
risk for distress at baseline, both of which warrant
further study. With fewer patients in the recurrent
and advanced phases versus patients in the newly
diagnosed phase, the power to detect moderation
may have been limited. Furthermore, although risk
for distress can predict accurately patients’ later risk
status, we need to examine more closely how risk
status affects patients’ response to a psychosocial
intervention.
There were some limitations to the current study
that should be noted. Because only a few interven-
tion studies have been conducted with couples
facing prostate cancer, multiple comparisons were
conducted to examine possible intervention effects,
increasing the possibility of Type I error (ie, chance
findings). Furthermore, the numbers of patients in
the biochemical and advanced phases were small
and may have limited our power to detect possible
moderation among the phases of illness. Finally, all
patients had partners in this study, which limits the
ability to generalize the current findings to patients
without spouses.
Given the positive effects of the intervention,
what are the implications for clinical practice? At a
minimum, the findings suggest that spouses of men
with prostate cancer need to be included in pro-
grams of care. Too often, they are viewed as outside
observers or only as providers of care. Instead, clini-
cians need to recognize that spouses are affected by
the cancer and to treat them as corecipients of care.
If patients are willing, then clinicians should include
spouses in consultation sessions. They need to
inquire about spouses’ concerns and provide infor-
mation to facilitate their caregiving role. By interven-
ing jointly with patients and spouses, clinicians can
help both individuals to gain information and obtain
support, which may reduce their uncertainty and
facilitate communication about the illness. Ideally,
structured and systematic programs of care would
help couples to cope with the effects of cancer. Fur-
ther research is needed on cost-effective ways to
deliver programs of care to patients and spouses in
busy clinic settings.
REFERENCES
1. Kornblith AB, Herr HW, Ofman US, et al. Quality of life of
patients with prostate cancer and their spouses. The value
of a data base in clinical care. Cancer. 1994;73:2791–2802.
2. Boehmer U, Clark JA. Communication about prostate can-
cer between men and their wives. J Fam Pract. 2001;50:
226–231.
3. Manne S, Babb J, Pinover W, et al. Psychoeducational
group intervention for wives of men with prostate cancer.
Psychooncology. 2004;13:37–46.
4. Northouse LL, Mood DW, Montie JE, et al. Living with
prostate cancer: Patients’ and spouses’ psychosocial status
and quality of life. J Clin Oncol. 2007;25:4171–4177.
5. Thornton AA, Perez MA, Meyerowitz BE. Patient and part-
ner quality of life and psychosocial adjustment following
radical prostatectomy. J Clin Psychol Med Settings. 2004;
11:15–30.
6. Davison BJ, Degner LF. Empowerment of men newly diag-
nosed with prostate cancer. Cancer Nurs. 1997;20:187–196.
7. Giesler RB, Given BA, Given CW, et al. Improving the qual-
ity of life of patients with prostate carcinoma. Cancer.
2005;104:752–762.
8. Lepore SJ, Helgeson VS. Psychoeducational support group
enhances quality of life after prostate cancer. Cancer Res
Ther Contr. 1999;8:81–91.
9. Mishel MH, Belyea M, Germino BB, et al. Helping patients
with localized prostate carcinoma manage uncertainty and
treatment side effects: nurse-delivered psychoeducational
intervention over the telephone. Cancer. 2002;94:1854–1866.
Clinical Trial of Family Intervention/Northouse et al. 2817
10. Weber BA, Roberts BL, Resnick M, et al. The effect of dya-
dic intervention on self-efficacy, social support, and
depression for men with prostate cancer. Psychooncology.
2004;13:47–60.
11. Giarelli E, McCorkle R, Monturo C. Caring for a spouse af-
ter prostate surgery: the preparedness needs of wives. J
Fam Nurs. 2003;9:453–485.
12. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New
York, NY: Springer; 1984.
13. Northouse LL, Rossett T, Phillips L, et al. Research with
families facing cancer: the challenge of accrual and reten-
tion. Res Nurs Health. 2006;29:199–211.
14. Northouse L, Kershaw T, Mood D, et al. Effects of a family
intervention on the quality of life of women with recurrent
breast cancer and their family caregivers. Psychooncology.
2005;14:478–491.
15. Northouse LL, Walker J, Schafenacker A, et al. A family-
based program of care for women with recurrent breast
cancer and their family members. Oncol Nurs Forum.
2002;29:1411–1419.
16. Ware J, Kosinski M, Keller SD. A 12-item short-form health
survey: construction of scales and preliminary tests of
reliability and validity. Med Care. 1996;34:220–233.
17. Cella D, Tulsky D, Gray G, et al. The Functional Assessment
of Cancer Therapy scale: development and validation of
the general measure. J Clin Oncol. 1993;11:570–579.
18. Oberst MT. Appraisal of Illness and Caregiving Scales: Man-
uals for Use. Detroit, Mich: Wayne State University; 1991.
19. Mishel M, Epstein D. Uncertainty in Illness Scales Manual.
Tucson, Ariz: University of Arizona; 1990.
20. Beck AT, Weissman A, Lester D, et al. The measurement of
pessimism: the Hopelessness Scale. J Consult Clin Psychol.
1974;42:861–865.
21. Carver CS. You want to measure coping but your protocol’s
too long: consider the Brief COPE. Int J Behav Med. 1997;
4:92–100.
22. Lewis FM. Family Home Visitation Study Final Report. Be-
thesda, Md: National Cancer Institute, National Institutes
of Health; 1996.
23. Mood D, Bickes J. Strategies to enhance self-care in radia-
tion therapy. Oncol Nurs Forum. 1989;16(suppl):143.
24. Wei JT, Dunn RL, Litwin MS, et al. Development and vali-
dation of the Expanded Prostate Cancer Index Composite
(EPIC) for comprehensive assessment of health-related
quality of life in men with prostate cancer. Urology.
2000;56:899–905.
25. Weisman AD. Coping With Cancer. New York, NY: McGraw-
Hill; 1979.
26. Worden JW. Psychosocial screening of cancer patients.
J Psychosoc Oncol. 1983;1:1–10.
27. McMillan SC, Small BJ, Weitzner M, et al. Impact of coping
skills intervention with family caregivers of hospice
patients with cancer. Cancer. 2006;106:214–222.
28. Schulz R, Beach SR. Caregiving as a risk factor for mortal-
ity: the Caregiver Health Effects Study. JAMA. 1999;282:
2215–2229.
29. Brucker PS, Yost K, Cashy J, Webster K, et al. General
population and cancer patient norms for the functional
assessment of cancer therapy-general (FACT-G). Eval
Health Prof. 2005;28:192–211.
2818 CANCER December 15, 2007 / Volume 110 / Number 12
